Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vor Biopharma Q4 EPS $(0.49)

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.49) per share.

byBenzinga Newsdesk

March 14, 2022

1 minute read

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.49) per share.

Earnings

Looking Into Janux Therapeutics’s Return On Capital Employed

By Benzinga Insights

Today, 4:40 AM

According to Benzinga Pro data, during Q1, Janux Therapeutics (NASDAQ:JANX) posted sales of $1.59 million. Earnings were up 0.04%, but Janux Therapeutics still reported an overall loss of $13.41 million.

JANX

News
Rumors

PayPal Considering Apex, DriveWealth’s Bids For Stock-Trading Push

By Benzinga Newsdesk

Today, 4:40 AM

-Bloomberg

PYPL

Ross Stores’ Low Q4 Bar, Improving Inventory, Potential Trade Down Triggers 7% Price Target Hike By Morgan Stanley

By Shivani Kumaresan

Today, 4:40 AM

Morgan Stanley analyst Alex Straton reiterated an Overweight rating on the shares of Ross Stores Inc (NASDAQ:ROST) and raised the price target…

ROST

Mannatech Q2 EPS $0.99 Up From $0.47 YoY, Sales $42.50M Up From $37.65M YoY

By Benzinga Newsdesk

Today, 4:40 AM

Mannatech (NASDAQ:MTEX) reported quarterly earnings of $0.99 per share. This is a 110.64 percent increase over earnings of $0.47 per share from the same period last year. The company reported $42.50 million in sales

MTEX

Vor Biopharma Q4 EPS $(0.49)

Related Posts

Looking Into Janux Therapeutics’s Return On Capital Employed

PayPal Considering Apex, DriveWealth’s Bids For Stock-Trading Push

Ross Stores’ Low Q4 Bar, Improving Inventory, Potential Trade Down Triggers 7% Price Target Hike By Morgan Stanley

Mannatech Q2 EPS $0.99 Up From $0.47 YoY, Sales $42.50M Up From $37.65M YoY